Effect of β-blocker therapy in diabetic patients with stable coronary heart disease: a meta-analysis

BACKGROUND: β-blocker (BB) therapy is a cornerstone for the treatment of coronary heart disease (CHD). The evidence of the benefit from long-term BB therapy in diabetic patients with stable CHD is scarce. This meta-analysis summarizes the evidence relating to the BB therapy in diabetic patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Aaqib H, Shetty, Suchith, Kar, Kausik, El Accaoui, Ramzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500566/
https://www.ncbi.nlm.nih.gov/pubmed/31080472
http://dx.doi.org/10.11909/j.issn.1671-5411.2019.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500566/
https://www.ncbi.nlm.nih.gov/pubmed/31080472
http://dx.doi.org/10.11909/j.issn.1671-5411.2019.03.008

Ejemplares similares